# Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer

> **NCT02853110** · PHASE2 · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 100 (actual)

## Conditions studied

- Prostate Cancer Adenocarcinoma

## Interventions

- **RADIATION:** Hypo-FLAME study

## Key facts

- **NCT ID:** NCT02853110
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-12-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02853110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02853110, "Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02853110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*